Recombinant BCG vaccine - Aeras Global TB Vaccine Foundation/ UCLA
Alternative Names: rBCG30; recombinant Bacillus Calmette-Guerin 30Latest Information Update: 31 Jan 2007
Price :
$50 *
At a glance
- Originator University of California at Los Angeles
- Class Synthetic vaccines; Tuberculosis vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Tuberculosis
Most Recent Events
- 31 Jan 2007 No development reported - Phase-I for Tuberculosis in USA (unspecified route)
- 02 Mar 2004 Phase-I clinical trials in Tuberculosis in USA (unspecified route)